109 related articles for article (PubMed ID: 22179926)
1. Early diagnostic protein biomarkers for breast cancer: how far have we come?
Opstal-van Winden AW; Vermeulen RC; Peeters PH; Beijnen JH; van Gils CH
Breast Cancer Res Treat; 2012 Jul; 134(1):1-12. PubMed ID: 22179926
[TBL] [Abstract][Full Text] [Related]
2. Serum degradome markers for the detection of breast cancer.
van Winden AW; van den Broek I; Gast MC; Engwegen JY; Sparidans RW; van Dulken EJ; Depla AC; Cats A; Schellens JH; Peeters PH; Beijnen JH; van Gils CH
J Proteome Res; 2010 Aug; 9(8):3781-8. PubMed ID: 20557135
[TBL] [Abstract][Full Text] [Related]
3. Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples.
van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1842-50. PubMed ID: 20533314
[TBL] [Abstract][Full Text] [Related]
4. Use of serological proteomic methods to find biomarkers associated with breast cancer.
Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R
Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
[TBL] [Abstract][Full Text] [Related]
5. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
6. [Proteomics and breast cancer].
Mathelin C; Tomasetto C; Cromer A; Rio MC
Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
[TBL] [Abstract][Full Text] [Related]
7. Surface-enhanced Laser Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer Markers in Tears and Serum.
Lebrecht A; Boehm D; Schmidt M; Koelbl H; Grus FH
Cancer Genomics Proteomics; 2009; 6(2):75-83. PubMed ID: 19451091
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
[TBL] [Abstract][Full Text] [Related]
9. Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay.
Song J; Patel M; Rosenzweig CN; Chan-Li Y; Sokoll LJ; Fung ET; Choi-Miura NH; Goggins M; Chan DW; Zhang Z
Clin Chem; 2006 Jun; 52(6):1045-53. PubMed ID: 16574760
[TBL] [Abstract][Full Text] [Related]
10. [Application of serum proteomic mass spectrum analysis in breast cancer].
Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
[TBL] [Abstract][Full Text] [Related]
11. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
12. Serum protein profiling for diagnosis of breast cancer using SELDI-TOF MS.
Gast MC; Van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Oncol Rep; 2009 Jul; 22(1):205-13. PubMed ID: 19513525
[TBL] [Abstract][Full Text] [Related]
13. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS.
Zhang K; Yuan K; Wu H; Li Q; Wang Y; Chen S; Zhang L; Gu H; Fu R
Appl Biochem Biotechnol; 2012 Feb; 166(3):753-63. PubMed ID: 22127810
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic application of serum protein pattern and artificial neural network software in breast cancer].
Hu Y; Zhang SZ; Yu JK; Liu J; Zheng S; Hu X
Ai Zheng; 2005 Jan; 24(1):67-71. PubMed ID: 15642203
[TBL] [Abstract][Full Text] [Related]
16. The absolute quantification of eight inter-α-trypsin inhibitor heavy chain 4 (ITIH4)-derived peptides in serum from breast cancer patients.
van den Broek I; Sparidans RW; van Winden AW; Gast MC; van Dulken EJ; Schellens JH; Beijnen JH
Proteomics Clin Appl; 2010 Dec; 4(12):931-9. PubMed ID: 21137033
[TBL] [Abstract][Full Text] [Related]
17. Liquid chromatography/tandem mass spectrometric method for the quantification of eight proteolytic fragments of ITIH4 with biomarker potential in human plasma and serum.
van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2008 Sep; 22(18):2915-28. PubMed ID: 18752334
[TBL] [Abstract][Full Text] [Related]
18. Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samples.
Muraoka S; Kume H; Watanabe S; Adachi J; Kuwano M; Sato M; Kawasaki N; Kodera Y; Ishitobi M; Inaji H; Miyamoto Y; Kato K; Tomonaga T
J Proteome Res; 2012 Aug; 11(8):4201-10. PubMed ID: 22716024
[TBL] [Abstract][Full Text] [Related]
19. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
Gast MC; van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Clin Chem Lab Med; 2009; 47(6):694-705. PubMed ID: 19416081
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses.
Jayapalan JJ; Ng KL; Razack AH; Hashim OH
Electrophoresis; 2012 Jul; 33(12):1855-62. PubMed ID: 22740474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
